Family summary
Historical shortage references are available across related Ceftazidime presentations from multiple manufacturers.
- 0 current shortage context pages.
- 9 historical shortage context pages.
- 3 manufacturers represented.
Ceftazidime - Drug Shortage Information
Public shortage context is available across 9 visible exact NDC pages for this generic drug family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
Common brands and presentations in this family
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
ceftazidime 1 g / 1 Injection 25 Vial - NDC 25021-0127-20Sagent Pharmaceuticals | 25 Vialceftazidime 2 g / 1 Injection 10 Vial - NDC 25021-0128-50Sagent Pharmaceuticals | 10 VialCeftazidime 1 g / 1 Injection 25 Vial (Tazicef) - NDC 00409-5082-16Hospira, Inc. | 25 VialCeftazidime 2 g / 1 Injection 10 Vial (Tazicef) - NDC 00409-5084-11Hospira, Inc. | 10 VialCeftazidime 6 g / 1 Injection 10 Vial, Pharmacy Bulk Package (Tazicef) - NDC 00409-5086-11Hospira, Inc. | 10 Vial, Pharmacy Bulk Package
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.